Skip to content

Within-Individual Variability of Resting Metabolic Rate Over 12 Weeks

Within-Individual Variability of Resting Metabolic Rate Assessed Repeatedly Over 12 Weeks Using Whole-Room Calorimetry

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07628764
Enrollment
30
Registered
2026-06-05
Start date
2026-07-01
Completion date
2027-12-01
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Energy Metabolism, Resting Metabolic Rate

Keywords

Resting Metabolic Rate, Energy Expenditure, Metabolism, Indirect Calorimetry, Variability

Brief summary

This prospective observational study aims to characterize within-individual variability in resting metabolic rate (RMR) over a 12-week period using high-frequency repeated measurements under standardized conditions. Participants will undergo RMR assessments three times per week using whole-room indirect calorimetry. The study will quantify the magnitude of physiological variability in RMR, distinguish true biological variation from measurement error, and estimate the minimal detectable change required to identify meaningful metabolic adaptations.

Detailed description

Resting metabolic rate (RMR) is a major component of total daily energy expenditure and is widely used in metabolic research. However, most studies rely on single or infrequent measurements, assuming RMR is stable within individuals. Emerging evidence suggests that RMR exhibits measurable within-individual variability, but the temporal structure and magnitude of this variability remain poorly characterized. This study will implement a high-frequency repeated-measures design, with RMR measured three times per week over 12 weeks using whole-room indirect calorimetry under standardized conditions. This approach will allow detailed characterization of short-term variability and provide estimates for within-subject variability, measurement error, and minimal detectable change. The findings will inform interpretation of longitudinal metabolic studies and improve study design in future research.

Interventions

OTHERRepeated Measurement of Resting Metabolic Rate

Repeated assessment of resting metabolic rate under standardized conditions; no intervention is administered.

Sponsors

Tel Aviv University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18-65 years * Clinically healthy individuals * Stable body weight (±2 kg) over the past 3 months * Ability and willingness to attend morning measurements three times per week for 12 weeks * Ability to provide informed consent

Exclusion criteria

* Known uncontrolled endocrine or metabolic disease * Use of medications known to significantly affect resting metabolic rate (e.g., systemic corticosteroids, unstable thyroid hormone therapy) * Acute illness within 14 days prior to enrollment * Pregnancy or lactation * Any medical condition that, in the opinion of the investigators, may interfere with safe participation

Design outcomes

Primary

MeasureTime frameDescription
Within-Individual Variability in Resting Metabolic Rate (RMR)12 weeksWithin-individual variability in resting metabolic rate (RMR) assessed using repeated measurements under standardized conditions. Variability will be quantified using mean, standard deviation (SD), and coefficient of variation (CV%) across repeated measurements.

Secondary

MeasureTime frameDescription
Minimal Detectable Change (MDC) in RMR12 weeksThe minimal detectable change in resting metabolic rate required to distinguish true physiological change from measurement variability.
Between-Individual Variability in RMR12 weeksAssessment of variability in resting metabolic rate between participants based on repeated measurements.
Temporal Trends in RMR12 weeksAssessment of systematic changes in resting metabolic rate over time using repeated measurements across the study period.

Contacts

CONTACTYftach Prof. Gepner
gepner@tauex.tau.ac.il+972 50-682-8501
CONTACTLien Bruck
+972 587487431
PRINCIPAL_INVESTIGATORYftach Prof. Gepner

Tel Aviv University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026